Tabassum, N., & Yasmin, H. (2024). Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: A pharmacovigilance study. Brac University.
Cita Chicago (17th ed.)Tabassum, Nadira, i Hasina Yasmin. Gender-specific Rhabdomyolysis Risk in Alzheimer’s Disease Patients Receiving Memantine: A Pharmacovigilance Study. Brac University, 2024.
Cita MLA (8th ed.)Tabassum, Nadira, i Hasina Yasmin. Gender-specific Rhabdomyolysis Risk in Alzheimer’s Disease Patients Receiving Memantine: A Pharmacovigilance Study. Brac University, 2024.
Atenció: Aquestes cites poden no estar 100% correctes.